Medicina, Vol. 57 No. 1, 2021.
Pregledni rad
https://doi.org/10.21860/medflum2021_365327
Inherited thrombophilia
Petra Baumgartner
; Klinika za bolesti srca i krvnih žila, KBC Rijeka, Rijeka, Hrvatska
Toni Valković
; Zavod za hematologiju, KBC Rijeka; Medicinski fakultet i Fakultet zdravstvenih studija Sveučilišta u Rijeci, Rijeka, Hrvatska
Sažetak
The term thrombophilia implies inherited and/or acquired disorders of the hemostasis mechanism that predispose to the development of thrombosis. Inherited thrombophilia includes conditions in which an inherited genetic mutations affect the amount or function of proteins involved in the coagulation system, and as a consequence, an increased tendency to venous and, much less frequently, arterial thrombosis. Undoubtedly defined inherited thrombophilic conditions are the deficiency of antithrombin, protein C and protein S and the appearance of factor V Leiden and rothrombin's variants. There is still no clear recommendation for testing hereditary thrombophilia, and the prophylaxis and the treatment of thromboembolic events must be individualized.
Ključne riječi
antithrombin; factor V Leiden; inherited thrombophilia; protein C; protein S; prothrombin variant; thromboembolic events
Hrčak ID:
251266
URI
Datum izdavanja:
1.3.2021.
Posjeta: 3.855 *